Research

  1. Baylor College of Medicine
  2. Research
  3. Research Centers
  4. Texas Developmental Center for AIDS Research
  5. Grants and Funding

Texas D-CFAR Grants and Funding

Master
Content

We provide our members with support to do cutting-edge research through:

  • Introductions to collaborators from our home institutions and the wider network of HIV-leading investigators
  • Identifying opportunities for funding through NIH or other funding bodies
  • Providing strategies for competitive grant applications and feedback from senior investigators on grant drafts  
  • Assistance with organizing multi-investigator grant submissions
  • Offering pilot grant funding to jumpstart or supplement your research endeavors

Submitting a grant?

Our Texas D-CFAR leadership can do a “mock review” to help you prepare a competitive grant application. 

The mock review process helped me get unique perspectives on my grant submission, in-depth actionable feedback, and the special opportunity to ask questions and brainstorm ways to address any potential concerns with my submission.

Annalynn “Anna” Maguddayao Galvin, Ph.D., RN, UT-Health Cizik School of Nursing
Content

For funding opportunities visit the following sites:

Notice of Extension of NOT-HL-20-761 "Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood". Expires Jan. 1, 2025

Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed). Expires July 2, 2024

Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States. Expires Oct. 18, 2024

Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required). Expires July 2, 2024

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed). Expires July 2, 2024

Notice of Expiration of NOT-HL-19-677 "Notice of Special Interest SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)". Expires Jan. 1, 2025

Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed). Expires July 2, 2024

Application Due Date Changes for RFA-HL-23-013, "Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)". Expires Jan. 1, 2025

Application Due Date Changes for RFA-HL-23-014, "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33)". Expires Jan. 1, 2025

Notice of Application Due Date Changes for RFA-HL-23-011,"Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)". Expires Jan. 1, 2025

NIMH FOAs

NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment, and Cure

NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others

Co-Sponsored FOAs

NOT-AI-21-054: Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV

NOT-AI-21-057: Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide

NOT-CA-22-037: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research

NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings

NOT-OD-21-100: Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health

NOT-AI-21-011: Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research

NOT-CA-22-037: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research

NOT-MH-22-095: Notice of Special Interest: NIMH Priorities on Aggression and Violence Against Others

PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

PAR-21-297: Novel Systemic Options for Young Adults under the tab PA-Joint; Multipurpose Prevention Technology 

PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults